Fulgent Genetics
FLGT
224 hedge funds and large institutions have $367M invested in Fulgent Genetics in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 78 reducing their positions, and 40 closing their positions.
38% more call options, than puts
Call options by funds: $10.1M | Put options by funds: $7.33M
0.55% more ownership
Funds ownership: 44.07% → 44.62% (+0.55%)
5% less funds holding
Funds holding: 235 → 224 (-11)
18% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 78
20% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 40
28% less capital invested
Capital invested by funds: $508M → $367M (-$141M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.06M |
| 2 |
JP Morgan Chase
New York
|
+$5.18M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.2M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$3.42M |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$6.35M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.09M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.85M |
| 4 |
Renaissance Technologies
New York
|
-$3.55M |
| 5 |
Millennium Management
New York
|
-$3.3M |
FLGT Hedge Fund Activity: Q4 2022 in Review
224 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2022, worth a combined $367M — down 28% from $508M a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of FLGT and 32 opened new positions — a net loss of 8 holders — while 78 trimmed existing stakes and 64 added.
The largest buyer was Federated Hermes, adding an estimated $7.06M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $6.35M sold.
- 224 institutional investors held Fulgent Genetics (FLGT) as of Q4 2022, down from 235 in Q3 2022.
- Funds reported $367M of Fulgent Genetics stock for Q4 2022, down 28% quarter-over-quarter.
- 32 funds opened new Fulgent Genetics positions in Q4 2022 and 40 closed out, a net change of -8 holders.
- The largest Fulgent Genetics buyer in Q4 2022 was Federated Hermes, an estimated $7.06M added.
- The largest Fulgent Genetics seller in Q4 2022 was Baker Bros. Advisors, an estimated $6.35M sold.
Based on aggregated 13F filings for Q4 2022.